Estimation of prevention-effective CAB-LA concentrations among men who have sex with men (MSM) and transgender women (TGW) in HPTN 083

By afschroeder • November 9, 2025

Hanscom B, Marzinke MA, Li X, Donnell D, Bies R, Hendrix CW, Wang Z, Acuipil C, Rinehart A, Collins JW, Rooney JF, Soto Torres L, Richardson P, Chariyalerstsak S, Valdez Ramalho Madruga J, Hurt CB, Magnus M, Frank I, McCauley M, Grinsztejn B, Landovitz RJ. Estimation of prevention-effective CAB-LA concentrations among men who have sex with men (MSM) and transgender women (TGW) in HPTN 083. J Infect Dis. 2025 Nov 5:jiaf561. doi: 10.1093/infdis/jiaf561. Epub ahead of print. PMID: 41206027.

Tags: Cabotegravir, Cabotegravir Pharmacokinetics, HIV PrEP, HPTN 083, Infectious Diseases, Long-acting PrEP, Publications

Missed Opportunities for HIV and Syphilis Co-Testing in Emergency Departments

Sherwood K, Zhang N, David H, Dekker A, Garner O, Samuels E, Adamson P. Missed Opportunities for HIV and Syphilis Co-Testing in Emergency Departments. Clin[...]

Virulence Phenotypes Differentiate Persistent vs. Resolving Isolates of Human Staphylococcus aureusBacteremia

Chan LC, Lee HK, Wang L, Wang H, Filler SG, Ciranna A, Abdelhady W, Xiong YQ, Li L, Gonzales RA, Ruffin F, Fowler VG Jr,[...]

Prospective HIV RNA screening with long-acting cabotegravir pre-exposure prophylaxis in HPTN 083

Landovitz RJ, Fogel JM, Gao F, Hanscom B, Piwowar-Manning E, Moser A, Marzinke MA, Cyktor J, Seisa M, Halvas EK, Kofron R, Jennings A, Clement[...]